Terms: = Lung cancer AND PCSK7, Q16549, 9159, ENSG00000160613, PC8, SPC7, PC7, LPC AND Treatment
18 results:
1. Lipidomics reveals immune-related adverse events in NSCLC patients receiving immune checkpoint inhibitor.
Yu J; Xiong F; Xu Y; Xu H; Zhang X; Gao H; Li Y
Int Immunopharmacol; 2024 Jan; 127():111412. PubMed ID: 38160567
[TBL] [Abstract] [Full Text] [Related]
2. Assessment of plasma amino acids, purines, tricarboxylic acid cycle metabolites, and lipids levels in NSCLC patients based on LC-MS/MS quantification.
Cang S; Liu R; Mu K; Tang Q; Cui H; Bi K; Zhang Y; Li Q
J Pharm Biomed Anal; 2022 Nov; 221():114990. PubMed ID: 36208488
[TBL] [Abstract] [Full Text] [Related]
3. Activation of the Notch1-c-myc-VCAM1 signalling axis initiates liver progenitor cell-driven hepatocarcinogenesis and pulmonary metastasis.
Wu WR; Shi XD; Zhang FP; Zhu K; Zhang R; Yu XH; Qin YF; He SP; Fu HW; Zhang L; Zeng H; Zhu MS; Xu LB; Wong PP; Liu C
Oncogene; 2022 Apr; 41(16):2340-2356. PubMed ID: 35256782
[TBL] [Abstract] [Full Text] [Related]
4. Adaptive Lumpectomy Boost Planning Can Reduce Normal Tissue Exposure in Patients Receiving Hypofractionated Whole Breast Irradiation.
Sayan M; Yehia ZA; Jan I; Gupta A; Vergalasova I; Reviello M; Kumar S; Haffty B; Ohri N
Anticancer Res; 2022 Jan; 42(1):53-57. PubMed ID: 34969708
[TBL] [Abstract] [Full Text] [Related]
5. Mass spectrometry imaging revealed alterations of lipid metabolites in multicellular tumor spheroids in response to hydroxychloroquine.
Chen Y; Wang T; Xie P; Song Y; Wang J; Cai Z
Anal Chim Acta; 2021 Nov; 1184():339011. PubMed ID: 34625248
[TBL] [Abstract] [Full Text] [Related]
6. Intranasal delivery of cationic liposome-protamine complex mRNA vaccine elicits effective anti-tumor immunity.
Mai Y; Guo J; Zhao Y; Ma S; Hou Y; Yang J
Cell Immunol; 2020 Aug; 354():104143. PubMed ID: 32563850
[TBL] [Abstract] [Full Text] [Related]
7. Clinical significance of circulating tumor cells and metabolic signatures in lung cancer after surgical removal.
Yang D; Yang X; Li Y; Zhao P; Fu R; Ren T; Hu P; Wu Y; Yang H; Guo N
J Transl Med; 2020 Jun; 18(1):243. PubMed ID: 32552826
[TBL] [Abstract] [Full Text] [Related]
8. A Novel Strategy for Targeted Lipidomics Based on LC-Tandem-MS Parameters Prediction, Quantification, and Multiple Statistical Data Mining: Evaluation of Lysophosphatidylcholines as Potential cancer Biomarkers.
Zhang Q; Xu H; Liu R; Gao P; Yang X; Jin W; Zhang Y; Bi K; Li Q
Anal Chem; 2019 Mar; 91(5):3389-3396. PubMed ID: 30689358
[TBL] [Abstract] [Full Text] [Related]
9. Dosimetric effects of the kV based image-guided radiation therapy of prone breast external beam radiation: Towards the optimized imaging frequency.
Xu H; Lee SW; Guerrero M; Yi BY; Chen S; Becker SJ; Chung H; Cheston SB
J Appl Clin Med Phys; 2019 Jan; 20(1):212-219. PubMed ID: 30550644
[TBL] [Abstract] [Full Text] [Related]
10. Comparison of efficacy and safety between liposome-paclitaxel injection plus carboplatin and paclitaxel plus carboplatin as first line treatment in advanced non-small cell lung cancer.
Wang HY; Zhang XR
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2014 Jun; 36(3):305-8. PubMed ID: 24997825
[TBL] [Abstract] [Full Text] [Related]
11. Benzyl and naphthalene methylphosphonic acid inhibitors of autotaxin with anti-invasive and anti-metastatic activity.
Gupte R; Patil R; Liu J; Wang Y; Lee SC; Fujiwara Y; Fells J; Bolen AL; Emmons-Thompson K; Yates CR; Siddam A; Panupinthu N; Pham TC; Baker DL; Parrill AL; Mills GB; Tigyi G; Miller DD
ChemMedChem; 2011 May; 6(5):922-35. PubMed ID: 21465666
[TBL] [Abstract] [Full Text] [Related]
12. In vitro simulation study of individualized chemotherapy in lung cancer.
Li C; Gemma A; Minegishi Y; Matsuda K; Seike Y; Noro R; Shionoya A; Kawakami A; Ogawa N; Kudoh S
J Nippon Med Sch; 2007 Jun; 74(3):217-22. PubMed ID: 17625370
[TBL] [Abstract] [Full Text] [Related]
13. Tumor efficacy and biodistribution of linear polyethylenimine-cholesterol/DNA complexes.
Furgeson DY; Yockman JW; Janat MM; Kim SW
Mol Ther; 2004 Jun; 9(6):837-45. PubMed ID: 15194050
[TBL] [Abstract] [Full Text] [Related]
14. Lethal pulmonary toxicity after autologous bone marrow transplantation/peripheral blood stem cell transplantation for hematological malignancies.
Lohr F; Wenz F; Schraube P; Flentje M; Haas R; Zierhut D; Fehrentz D; Hunstein W; Wannenmacher M
Radiother Oncol; 1998 Jul; 48(1):45-51. PubMed ID: 9756171
[TBL] [Abstract] [Full Text] [Related]
15. Augmented lung adenocarcinoma cytotoxicity by the combination of a genetically modified anti-Lewis Y antibody and antibodies to complement regulatory proteins.
Azuma A; Yamano Y; Yoshimura A; Hibino T; Nishida T; Yagita H; Okumura K; Seya T; Kannagi R; Shibuya M
Scand J Immunol; 1995 Aug; 42(2):202-8. PubMed ID: 7543216
[TBL] [Abstract] [Full Text] [Related]
16. Mechanisms of collateral sensitivity to fluorouracil of a cis-diamminedichloroplatinum(II)-resistant human non-small lung cancer cell line.
Sugimoto Y; Ohe Y; Nishio K; Ohmori T; Morikage T; Fujiwara Y; Saijo N
Br J Cancer; 1992 Jun; 65(6):857-64. PubMed ID: 1319727
[TBL] [Abstract] [Full Text] [Related]
17. Establishment of a camptothecin analogue (CPT-11)-resistant cell line of human non-small cell lung cancer: characterization and mechanism of resistance.
Kanzawa F; Sugimoto Y; Minato K; Kasahara K; Bungo M; Nakagawa K; Fujiwara Y; Liu LF; Saijo N
Cancer Res; 1990 Sep; 50(18):5919-24. PubMed ID: 2168285
[TBL] [Abstract] [Full Text] [Related]
18. Colony inhibitory effect of recombinant human tumor necrosis factor (rH-TNF) and/or recombinant human interferon (rH-IFN)-alpha, -beta and -gamma on human lung cancer cell lines.
Hong WS; Jett JR; Sasaki Y; Takahashi H; Nakano H; Nakagawa K; Hoshi A; Saijo N
Jpn J Clin Oncol; 1987 Mar; 17(1):49-55. PubMed ID: 2435930
[TBL] [Abstract] [Full Text] [Related]
